Genetic Technologies Limited advised that Mr. Tony Di Pietro has provided his notice of resignation as Chief Financial Officer (CFO) of the Company. The Company has commenced a search for a new CFO with requisite dual ASX and Nasdaq listed company expertise. Mr. Di Pietro will remain in the role of CFO until a replacement commences with GTG or the end of March 2024, whichever date is the earliest.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 AUD | -.--% | -9.09% | -25.93% |
1st Jan change | Capi. | |
---|---|---|
-25.93% | 8.78M | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
-1.55% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+79.20% | 13.21B | |
+70.11% | 13.08B | |
+40.44% | 12.9B |
- Stock Market
- Equities
- GTG Stock
- News Genetic Technologies Limited
- Genetic Technologies Limited Announces Resignation of Tony Di Pietro as Chief Financial Officer